Using the bioinformatics analyses, we found that the expression of CHD1L mRNA and protein in ovarian serous cancer was significantly higher than that in normal ovarian tissues, which was similar to our previous study based on tissue microarrays [20]. The gene discussed is CHD1L; the disease is ovarian serous adenocarcinoma.